Hogan Lovells hires Hatch-Waxman litigators
The firm's newest life sciences partners are patent litigators in biotech and pharma fields | Duo have secured Hatch-Waxman litigation victories.
Hogan Lovells has added life sciences patent litigators, Howard Levine and Jennifer Swan to its IP team as partners.
The duo joined Hogan Lovells’ global regulatory and IP, media, and technology practice group and the life sciences and healthcare sector
Both make the move from Dechert, and Levine will be based in Hogan Lovells’ Washington, DC office, while Swan will be in the Silicon Valley office.
Levine and Swan recently scored victories at the district court and the Federal Circuit in Hatch-Waxman litigation.
Lynn Mehler, global co-lead for Hogan Lovells' life sciences and health care industry sector group, said: "Howard and Jennifer's arrival adds in-demand IP strength at a time when many of our life sciences clients are involved in complex Hatch-Waxman litigation and matters involving the written description requirement under 35 U.S.C. § 112, among other matters.
“With their stellar reputations as patent litigators, we are excited to welcome them to our team," she added.
Throughout Levine’s 30-year career, he has advised on complex and high-value biotechnology and pharmaceutical patent litigation cases.
He has been at the forefront of legal developments in this space, including precedent concerning the written description requirement under 35 U.S.C. § 112.
Levine has been lead counsel in district court litigations throughout the country and in appeals before the US Court of Appeals for the Federal Circuit.
Ajay Kuntamukkala, Hogan Lovells' office managing partner for Washington, DC, highlighted Levine’s “strong reputation for representing innovator clients” in the last thirty years.
Swan has experience in enforcing and defending patent rights in biotechnology and pharmaceutical sectors.
Her expertise includes representing companies in patent litigation, while also assisting life science start-ups with strategic counselling.
She has participated in numerous appellate proceedings in the US Court of Appeals for the Federal Circuit and has contributed to recent developments in patent law, including the concept of joint infringement.
Celine Jimenez Crowson, the leader of Hogan Lovells' IPMT practice in the Americas, said: "Howard and Jennifer are both highly regarded life sciences patent litigators who bring exceptional experience in an industry that is a significant focus for the firm. We're thrilled to have them on board."
Did you enjoy reading this story? Sign up to our free daily newsletters and get stories sent like this straight to your inbox.
